[1] Reverri, E., Devitt, A., Kajzer, J., Baggs, G., & Borschel, M. (2018). Review of the clinical experiences of feeding infants formula containing the human milk oligosaccharide 2-fucosyllactose. Nutrients, 10(10).
[2]. Yu, Z. T., Chen, C., Kling, D. E., Liu, B., McCoy, J. M., Merighi, M., ... & Newburg, D. S. (2013). The principal fucosylated oligosaccharides of human milk exhibit prebiotic properties on cultured infant microbiota. Glycobiology, 23(2), 169-177.
[3]. Salli, K., Anglenius, H., Hirvonen, J., Hibberd, A. A., Ahonen, I., Saarinen, M. T., ... & Ouwehand, A. C. (2019). The effect of 2′-fucosyllactose on simulated infant gut microbiome and metabolites; a pilot study in comparison to GOS and lactose. Scientific reports, 9(1), 13232.
[4]. Vazquez, E., Barranco, A., Ramirez, M., Gruart, A., Delgado-Garcia, J. M., Jimenez, M. L., ... & Rueda, R. (2016). Dietary 2’-fucosyllactose enhances operant conditioning and long-term potentiation via gut-brain communication through the vagus nerve in rodents. PLos One, 11(11), e0166070.
[5]. Palsson, O. S., Peery, A., Seitzberg, D., Amundsen, I. D., McConnell, B., & Simrén, M. (2020). Human milk oligosaccharides support normal bowel function and improve symptoms of irritable bowel syndrome: a multicenter, open-label trial. Clinical and translational gastroenterology, 11(12).